TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32812824

Group type: EXPERIMENTAL
Intervention: Obese breast cancer survivors
Number of subjects: 105
Study: 33200905

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg/die plus tamsulosin 0.4 mg/die combination therapy for 12 weeks
Number of subjects: 50
Study: 33318108

Group type: EXPERIMENTAL
Intervention: Low-intensity lifestyle modification programme
Number of subjects: 0
Study: 34995334

Group type: EXPERIMENTAL
Intervention: 20-m walkway
Number of subjects: 50

Group type: COMPARATOR
Intervention: 30-m walkway
Number of subjects: 50
Study: 34196924

Group type: EXPERIMENTAL
Intervention: Eversense implantable sensor (EVS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Dexcom G5 transcutaneous sensor (DG5)
Number of subjects: 16
Study: 33334838

Group type: EXPERIMENTAL
Intervention: Dexamethasone on days 1-4
Number of subjects: 280

Group type: COMPARATOR
Intervention: Dexamethasone on day 1 combined with NK1-RA, Palonosetron, and Olanzapine (5 mg)
Number of subjects: 280
Study: 35948896

Group type: EXPERIMENTAL
Intervention: ELEVATE intervention (one hour of training four days per week for 12 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ELEVATE intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist-control group (usual care for six months)
Number of subjects: 0
Study: 33771192

Group type: EXPERIMENTAL
Intervention: Leukodepletion filter
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard arterial filter (Control)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Leukodepletion filter and Standard arterial filter (Control)
Number of subjects: 64
Study: 32665032

Group type: EXPERIMENTAL
Intervention: Mosquito-disseminated pyriproxyfen (MD-PPF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study: 34981209

Group type: EXPERIMENTAL
Intervention: 4D echocardiography
Number of subjects: 1441

Group type: COMPARATOR
Intervention: 2D echocardiography
Number of subjects: 1441
Study: 34183717

Group type: EXPERIMENTAL
Intervention: Low-volume cycling training (60 min per week, low-to-moderate intensity)
Number of subjects: 24
Study: 32512498

Group type: EXPERIMENTAL
Intervention: Pediatrician-led Newborn Class
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (mothers who expressed a desire to attend the class but were discharged before a class was offered)
Number of subjects: 84
Study: 34275463

Group type: EXPERIMENTAL
Intervention: Worktivity mobile app (MA)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Worktivity mobile app plus SSWD (MA+SSWD)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 56
Study: 32112448

Group type: EXPERIMENTAL
Intervention: Afforestation
Number of subjects: 1575

Group type: EXPERIMENTAL
Intervention: Other climate engineering technologies (7 carbon dioxide removal measures and 3 solar radiation management measures)
Number of subjects: 1575

Group type: EXPERIMENTAL
Intervention: Perceived benefits across all technologies
Number of subjects: 1575

Group type: EXPERIMENTAL
Intervention: Trust in industry/science/government (for all technologies but afforestation)
Number of subjects: 1575

Group type: EXPERIMENTAL
Intervention: Perceived risks and tampering with nature
Number of subjects: 1575
Study: 34579067

Group type: EXPERIMENTAL
Intervention: Carotenoid supplementation (14 mg zeaxanthin/7 mg lutein)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Carotenoid supplementation
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 32471891

Group type: EXPERIMENTAL
Intervention: CHIPS administration
Number of subjects: 0
Study: 36167287

Group type: EXPERIMENTAL
Intervention: Oral naltrexone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35770558

Group type: EXPERIMENTAL
Intervention: Vibro-acupuncture (VA)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Manual acupuncture (MA)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo acupuncture (PA)
Number of subjects: 58
Study: 33789251

Group type: EXPERIMENTAL
Intervention: Anthocyanins (AC) 320 mg/day in the form of Medox® capsules for 28 days
Number of subjects: 26
Study: 33882052

Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 5082

Group type: EXPERIMENTAL
Intervention: Daily cigarette smoking
Number of subjects: 5082

Group type: EXPERIMENTAL
Intervention: Occasional cigarette smoking
Number of subjects: 5082

Group type: EXPERIMENTAL
Intervention: Daily e-cigarette use
Number of subjects: 5082

Group type: EXPERIMENTAL
Intervention: Occasional e-cigarette use
Number of subjects: 5082

Group type: EXPERIMENTAL
Intervention: Daily heated tobacco use
Number of subjects: 5082

Group type: EXPERIMENTAL
Intervention: Occasional heated tobacco use
Number of subjects: 5082

Group type: COMPARATOR
Intervention: Odds of occasional cigarette smoking
Number of subjects: 5082

Group type: COMPARATOR
Intervention: Odds of occasional e-cigarette use
Number of subjects: 5082

Group type: COMPARATOR
Intervention: Odds of daily cigarette smoking
Number of subjects: 5082

Group type: COMPARATOR
Intervention: Odds of daily heated tobacco use
Number of subjects: 5082
Study: 34001451

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDFT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low central venous pressure (low‐CVP)
Number of subjects: 40
Study: 32839957

Group type: EXPERIMENTAL
Intervention: Active continuous theta burst stimulation (cTBS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham continuous theta burst stimulation (cTBS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Distancing
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 30
Study: 34170096

Group type: EXPERIMENTAL
Intervention: Pathology-confirmed appendicitis (PCA)
Number of subjects: 1189

Group type: COMPARATOR
Intervention: Delayed diagnosis of appendicitis (DDA)
Number of subjects: 1189

Group type: COMPARATOR
Intervention: Negative appendectomy (NA)
Number of subjects: 1189
Study: 32538011

Group type: EXPERIMENTAL
Intervention: Acupuncture at Ciliao (BL 32) for 20 min, one hour after delivery (observation group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conditional control group with additional interventions (hot towel application and finger pressing)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Blank control group with routine nursing plan
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Acupuncture at Ciliao (BL 32) (observation group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conditional control group with additional interventions
Number of subjects: 180
Study: 35012927

Group type: EXPERIMENTAL
Intervention: Osimertinib 80 mg
Number of subjects: 682

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 682
Study: 35286913

Group type: EXPERIMENTAL
Intervention: MW032 (120 mg)
Number of subjects: 120
Study: 34959872

Group type: EXPERIMENTAL
Intervention: O2-water enriched by injection (110 mg O2·L-1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: O2-water enriched by electrolysis (110 mg O2·L-1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo water (10 mg O2·L-1)
Number of subjects: 20
Study: 33794971

Group type: EXPERIMENTAL
Intervention: 7-session Family Talk programme (n = 96)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard care (n = 48)
Number of subjects: 144
Study: 32019559

Group type: EXPERIMENTAL
Intervention: Ergonomic plus exercise intervention (EET)
Number of subjects: 764

Group type: COMPARATOR
Intervention: Ergonomic plus health promotion intervention (EHP)
Number of subjects: 764
Study: 35241130

Group type: EXPERIMENTAL
Intervention: Transcutaneous electroacupuncture (TEA) on bilateral acupoints of Zusanli (ST36) and Neiguan (PC6) for 4 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham transcutaneous electroacupuncture (sham-TEA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Transcutaneous electroacupuncture (TEA)
Number of subjects: 90
Study: 34047704

Group type: EXPERIMENTAL
Intervention: movr app
Number of subjects: 48

Group type: COMPARATOR
Intervention: waitlist control
Number of subjects: 48
Study: 36179677

Group type: EXPERIMENTAL
Intervention: Responsible Behavior with Younger Children (RBYC) intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 160
Study: 33862286

Group type: EXPERIMENTAL
Intervention: Intensive, functional, gamified training program using the ArmAble™ device
Number of subjects: 120

Group type: COMPARATOR
Intervention: Task-based training along with conventional therapy
Number of subjects: 120
Study: 32354362

Group type: EXPERIMENTAL
Intervention: Septoplasty (N=102)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Non-surgical management (N=101)
Number of subjects: 203
Study: 36459760

Group type: EXPERIMENTAL
Intervention: Enhanced forms of prenatal care
Number of subjects: 201
Study: 35813320

Group type: EXPERIMENTAL
Intervention: Novel 3D ultrasound imedis9000
Number of subjects: 190

Group type: COMPARATOR
Intervention: Conventional 2D ultrasound instrument
Number of subjects: 190
Study: 32645714

Group type: EXPERIMENTAL
Intervention: 1 × 50L3
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2 × 50L3
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 3 × 50L3
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Repeated infection with hookworm larvae
Number of subjects: 24
Study: 33408197

Group type: EXPERIMENTAL
Intervention: Transcutaneous vagal nerve stimulation (tVNS)
Number of subjects: 120
Study: 32753637

Group type: EXPERIMENTAL
Intervention: L-Theanine (2.5 mg/kg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Caffeine (2.0 mg/kg)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: L-Theanine-caffeine combination
Number of subjects: 5
Study: 36150238

Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (2.5 mL orally every 8 hours for 1 month)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 36162692

Group type: EXPERIMENTAL
Intervention: Collaborative Assessment and Management of Suicidality (CAMS)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both CAMS and TAU
Number of subjects: 150
Study: 33518655

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT)
Number of subjects: 100
Study: 32758689

Group type: EXPERIMENTAL
Intervention: Novaferon
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Novaferon plus Lopinavir/Ritonavir
Number of subjects: 89

Group type: COMPARATOR
Intervention: Lopinavir/Ritonavir
Number of subjects: 89
Study: 34379080

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 1561

Group type: EXPERIMENTAL
Intervention: Multivariable prediction model
Number of subjects: 1561
Study: 35430674

Group type: EXPERIMENTAL
Intervention: Basal insulin treatment with fasting blood glucose (FBG) target of > 3.9 to ≤ 5.6 mmol/L
Number of subjects: 914

Group type: EXPERIMENTAL
Intervention: Basal insulin treatment with fasting blood glucose (FBG) target of > 3.9 to ≤ 6.1 mmol/L
Number of subjects: 914

Group type: EXPERIMENTAL
Intervention: Basal insulin treatment with fasting blood glucose (FBG) target of > 3.9 to ≤ 7.0 mmol/L
Number of subjects: 914

Group type: EXPERIMENTAL
Intervention: Basal insulin treatment
Number of subjects: 914
Study: 32224987

Group type: EXPERIMENTAL
Intervention: Tryptophan and magnesium-enriched Mediterranean diet (60 mg of TRY and 60 mg of MG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard Mediterranean diet
Number of subjects: 22
Study: 35970692

Group type: EXPERIMENTAL
Intervention: Educational and motivational messages through a WhatsApp channel
Number of subjects: 501

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 501
Study: 34265658

Group type: EXPERIMENTAL
Intervention: Social distancing primes
Number of subjects: 140

Group type: COMPARATOR
Intervention: Neutral primes
Number of subjects: 140
Study: 33010843

Group type: EXPERIMENTAL
Intervention: Manipulation under anaesthesia
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Arthroscopic capsular release
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Early structured physiotherapy
Number of subjects: 503
Study: 35977283

Group type: EXPERIMENTAL
Intervention: Behaviorally informed letters (8 variants)
Number of subjects: 744510

Group type: COMPARATOR
Intervention: Control group (no letters)
Number of subjects: 744510

Group type: EXPERIMENTAL
Intervention: Behaviorally informed letters (action language)
Number of subjects: 744510
Study: 34945237

Group type: EXPERIMENTAL
Intervention: Standard Mindfulness-Based Stress Reduction (MBSR) training
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Abbreviated Mindfulness-Based Stress Reduction (MBSR) training
Number of subjects: 112
Study: 32542474

Group type: EXPERIMENTAL
Intervention: Resilience‐Based Diabetes Self‐Management Education (RB‐DSME)
Number of subjects: 35
Study: 34003618

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32388492

Group type: EXPERIMENTAL
Intervention: HIE-identified hospital service utilization
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional methods (self-report)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional methods (self-report + single-system EHR review)
Number of subjects: 200
Study: 32886935

Group type: EXPERIMENTAL
Intervention: FCSEMS plus anchoring plastic stent
Number of subjects: 68

Group type: COMPARATOR
Intervention: FCSEMS alone
Number of subjects: 68
Study: 34049443

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine collaborative model of care (TCMCMC) with acupuncture
Number of subjects: 12
Study: 32064987

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 155
Study: 35799299

Group type: EXPERIMENTAL
Intervention: Antenatal milk expression (AME) intervention involving technique demonstration and feedback from a lactation consultant, daily independent practice, delivered at weekly visits at 37-40 weeks of pregnancy.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group receiving lactation education handouts.
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both AME and control groups (feeding any breast milk).
Number of subjects: 45
Study: 34485815

Group type: EXPERIMENTAL
Intervention: Adiponectin levels in tumors with high vs low TIL densities
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Adiponectin levels in obese vs nonobese patients
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Adiponectin levels in men vs women
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Adiponectin levels in Blacks vs Whites or Asians
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Adiponectin levels in patients with fewer lymph node metastases (N1 vs N2)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Insufficiency of 25(OH)D
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Adiponectin and 25(OH)D association with DFS, overall survival, or time to recurrence
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: TILs association with prognosis
Number of subjects: 600
Study: 35205786

Group type: EXPERIMENTAL
Intervention: Follow-up by physical examinations + whole-body imaging
Number of subjects: 204

Group type: COMPARATOR
Intervention: Follow-up by physical examinations only
Number of subjects: 204
Study: 33447960

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Socio-demographic factors, physical activity, and health status
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Total QoL score
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Physical health score
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Psychological health score
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Social relationship score
Number of subjects: 2562

Group type: EXPERIMENTAL
Intervention: Environment score
Number of subjects: 2562
Study: 35190388

Group type: EXPERIMENTAL
Intervention: PTED
Number of subjects: 613

Group type: COMPARATOR
Intervention: Open microdiscectomy
Number of subjects: 613
Study: 33879065

Group type: EXPERIMENTAL
Intervention: Internet-based behavioural activation (iBA) therapy, 12 weekly sessions with online assignments and feedback from trained therapists.
Number of subjects: 390

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Internet-based behavioural activation (iBA) therapy
Number of subjects: 390
Study: 32196826

Group type: EXPERIMENTAL
Intervention: Altered fractionation (AF) - 1.1 Gy + 2 Gy/d, 5 d/wk, 4.5 weeks, total dose 68 Gy
Number of subjects: 324

Group type: COMPARATOR
Intervention: Conventional fractionation (CF) - 2 Gy/d, 5 d/wk, 7 weeks, total dose 68 Gy
Number of subjects: 324
Study: 34657303

Group type: EXPERIMENTAL
Intervention: SGLT2i (dapagliflozin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34733978

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment applied at Baihui (GV20), Yintang (GV29), Shenmen (HT7, bilateral), and Sanyinjiao (SP6, bilateral) 3 times a week for 4 weeks.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham acupuncture using superficial needles on non-disorder-related acupoints 3 times a week for 4 weeks.
Number of subjects: 60
Study: 33706653

Group type: EXPERIMENTAL
Intervention: Subcutaneous insulin (SC‐I)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intravenous insulin (IV‐I)
Number of subjects: 19
Study: 32324850

Group type: EXPERIMENTAL
Intervention: Community-based mass testing and treatment (MTaT) performed 3 times per year for 2 years.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard of care for testing and treatment at public health facilities along with government‐sponsored mass long‐lasting insecticidal net [LLIN] distributions).
Number of subjects: 0
Study: 35015187

Group type: EXPERIMENTAL
Intervention: Antecedent-based techniques
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Consequent-based techniques
Number of subjects: 90

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 90
Study: 33793580

Group type: EXPERIMENTAL
Intervention: Branded Marevan
Number of subjects: 100

Group type: COMPARATOR
Intervention: União Química generic warfarin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Teuto generic warfarin
Number of subjects: 100
Study: 33378569

Group type: EXPERIMENTAL
Intervention: ibrutinib (IB)
Number of subjects: 675

Group type: COMPARATOR
Intervention: idelalisib-rituximab (IDELA-R)
Number of subjects: 675
Study: 36057254

Group type: EXPERIMENTAL
Intervention: Square-stepping exercise (SSE), 8 weeks, twice a week
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study: 33632284

Group type: EXPERIMENTAL
Intervention: uniportal video-assisted thoracic surgery (u-VATS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: three-port video-assisted thoracic surgery (t-VATS)
Number of subjects: 120
Study: 32730183

Group type: COMPARATOR
Intervention: R-CHOP-14
Number of subjects: 574

Group type: EXPERIMENTAL
Intervention: RR-CHOP-14
Number of subjects: 574
Study: 35974310

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided alveolar recruitment manoeuvres (UD group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained inflation alveolar recruitment manoeuvres (SI group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No recruitment manoeuvres (C group)
Number of subjects: 0
Study: 34698652

Group type: EXPERIMENTAL
Intervention: Peer-delivered booster sessions (N=245)
Number of subjects: 739

Group type: COMPARATOR
Intervention: Web-delivered booster sessions (N=246)
Number of subjects: 739
Study: 34043475

Group type: EXPERIMENTAL
Intervention: High-glycemic-index (HGI) meal
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low-glycemic-index (LGI) meal
Number of subjects: 18
Study: 33415872

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) applied at Zusanli (ST 36), Xuehai (SP 10), Sanyinjiao (SP 6) for 30 min each time, twice daily for 5 days.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional nursing combined with early functional exercise (20 min each time, twice daily for 5 days).
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rehabilitation training (20 min each time, twice daily for 5 days).
Number of subjects: 120
Study: 33538548

Group type: EXPERIMENTAL
Intervention: Laparoscopic CBD exploration with cholecystectomy (group I)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (EST) followed by laparoscopic cholecystectomy (group II)
Number of subjects: 77
Study: 32556595

Group type: EXPERIMENTAL
Intervention: Potassium chloride (KCl) supplementation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 32975171

Group type: EXPERIMENTAL
Intervention: Shoulder and scapula muscle training plus conventional physiotherapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 48
Study: 33098678

Group type: EXPERIMENTAL
Intervention: High-dose radiation (HDR, 45 + 18 Gy)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Radiochemotherapy (RCT, 45 Gy + 5FU infusion)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Sphincter-saving surgery (SSR)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Abdominoperineal resection (APR)
Number of subjects: 207
Study: 32615237

Group type: EXPERIMENTAL
Intervention: FDI criteria
Number of subjects: 160

Group type: COMPARATOR
Intervention: CARS criteria
Number of subjects: 160
Study: 34275868

Group type: EXPERIMENTAL
Intervention: Community-based distribution of HIV self-tests (HIVST) using OraQuick HIVST kits over 12 months.
Number of subjects: 148541

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 148541

Group type: EXPERIMENTAL
Intervention: Community-based distribution of HIV self-tests (HIVST)
Number of subjects: 148541
Study: 34024247

Group type: EXPERIMENTAL
Intervention: 2.7 kg MB
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 3.6 kg MB
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 4.5 kg MB
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 5.5 kg MB
Number of subjects: 31
Study: 35745183

Group type: EXPERIMENTAL
Intervention: Intensive mobile nutritional education for a year
Number of subjects: 203

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 203
Study: 34321204

Group type: EXPERIMENTAL
Intervention: Testosterone (genetic variants associated with testosterone levels)
Number of subjects: 306248